These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 11756711)
1. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Dill-Macky MJ; Burns PN; Khalili K; Wilson SR Radiology; 2002 Jan; 222(1):95-102. PubMed ID: 11756711 [TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions. Youk JH; Kim CS; Lee JM J Ultrasound Med; 2003 Sep; 22(9):897-910. PubMed ID: 14510261 [TBL] [Abstract][Full Text] [Related]
3. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180 [TBL] [Abstract][Full Text] [Related]
4. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US. Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304 [TBL] [Abstract][Full Text] [Related]
5. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent. Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639 [TBL] [Abstract][Full Text] [Related]
6. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669 [TBL] [Abstract][Full Text] [Related]
7. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Kim TK; Choi BI; Han JK; Hong HS; Park SH; Moon SG Radiology; 2000 Aug; 216(2):411-7. PubMed ID: 10924562 [TBL] [Abstract][Full Text] [Related]
8. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue]. Hohmann J; Skrok J; Puls R; Albrecht T Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698 [TBL] [Abstract][Full Text] [Related]
9. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314 [TBL] [Abstract][Full Text] [Related]
10. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience. Harvey CJ; Blomley MJ; Eckersley RJ; Cosgrove DO; Patel N; Heckemann RA; Butler-Barnes J Radiology; 2000 Sep; 216(3):903-8. PubMed ID: 10966730 [TBL] [Abstract][Full Text] [Related]
11. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience. Blomley MJ; Sidhu PS; Cosgrove DO; Albrecht T; Harvey CJ; Heckemann RA; Butler-Barnes J; Eckersley RJ; Basilico R Radiology; 2001 Sep; 220(3):661-7. PubMed ID: 11526264 [TBL] [Abstract][Full Text] [Related]
12. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Nino-Murcia M; Olcott EW; Jeffrey RB; Lamm RL; Beaulieu CF; Jain KA Radiology; 2000 Jun; 215(3):746-51. PubMed ID: 10831693 [TBL] [Abstract][Full Text] [Related]
14. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481 [TBL] [Abstract][Full Text] [Related]
15. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Bertolotto M; Dalla Palma L; Quaia E; Locatelli M Eur Radiol; 2000; 10(9):1369-76. PubMed ID: 10997422 [TBL] [Abstract][Full Text] [Related]
16. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US. Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251 [TBL] [Abstract][Full Text] [Related]
17. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers. Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691 [TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Isozaki T; Numata K; Kiba T; Hara K; Morimoto M; Sakaguchi T; Sekihara H; Kubota T; Shimada H; Morizane T; Tanaka K Radiology; 2003 Dec; 229(3):798-805. PubMed ID: 14563903 [TBL] [Abstract][Full Text] [Related]
19. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material. Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283 [TBL] [Abstract][Full Text] [Related]
20. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. von Herbay A; Vogt C; Häussinger D J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]